Kenneth A. Oye

Kenneth A. Oye

Auto-generated profile, based on publicly available information

Kenneth A. Oye

Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2014 in Science
Verified
Journal Article
Closed access
PDF file
KOKenneth A. Oye
Kenneth A. Oye
KEKevin Esvelt
Kevin Esvelt
EAEvan Appleton
Evan Appleton
FCFlaminia Catteruccia
Flaminia Catteruccia
GCGeorge Church
George Church
JCJames P. Collins
James P. Collins
Regulatory gaps must be filled before gene drives could be used in the wild

15 February 2012 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
HEH-G Eichler
H-G Eichler
KOK Oye
K Oye
LBL G Baird
L G Baird
EAE Abadie
E Abadie
JBJeffrey Brown
Jeffrey Brown
GHG Hirsch
G Hirsch

1 September 2009 in Politics and the Life Sciences
Verified
Journal Article
Open access
PDF file
GMGautam Mukunda
Gautam Mukunda
KOKenneth A. Oye
Kenneth A. Oye
SMScott C. Mohr
Scott C. Mohr
Synthetic biology seeks to create modular biological parts that can be assembled into useful devices, allowing the modification of biological systems with greater reliability, at lower cost, with greater speed, and by a larger pool of people than has been the case with traditional genetic engineering. We assess the offensive and defensive security implications of synthetic biology based on the insights of leading synthetic biologists into how the technology may develop, the projections of practicing biosecurity authorities on changes in the security context and potential security applications of synthetic biology, and joint appraisals of policy relevant sources of uncertainty. Synthetic biology appears to have minimal security implications in the near term, create modest offensive advantages in the medium term, and strengthen defensive capabilities against natural and engineered biological threats and enable novel potential offensive uses in the long term. To maximize defensive and minimize offensive effects of synthetic biology despite uncertainty, this essay suggests a combination of policy approaches, including community-based efforts, regulation and surveillance, further research, and the deliberate design of security and safety features into the technology.

12 September 2016 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
KOKa Oye
Ka Oye
HEHg Eichler
Hg Eichler
AHA Hoos
A Hoos
YMY Mori
Y Mori
TMTm Mullin
Tm Mullin
MPM Pearson
M Pearson

1 September 2013 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
KOK Oye
K Oye
LBL G Baird
L G Baird
ACA Chia
A Chia
SHS Hocking
S Hocking
PHP B Hutt
P B Hutt
VSV Salvatore
V Salvatore

3 August 2015 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
KOKa Oye
Ka Oye
GJG Jain
G Jain
MAM Amador
M Amador
RAR Arnaout
R Arnaout
JBJs Brown
Js Brown
GHG Hirsch
G Hirsch
Beneath most lively policy debates sit dry-as-dust theoretical and methodological discussions. Current disputes over the EU Adaptive Pathways initiative and the proposed US 21st Century Cures Act may ultimately rest on addressing arcane issues of data curation, standardization, and utilization. Improved extraction of inform ation on the safety and effectiveness of drugs-in-use must parallel adjustments in evidence requirements at the time of licensing. To do otherwise may compromise safety and efficacy in the name of fostering innovation